Among others, PACAP has been shown to reduce injuries in models of retinopathy of prematurity, diabetic retinopathy, and retinopathies induced by inflammation, ischemia, neurotoxicity, and UV light [8,17,19,21,22,23,27,28,29]. Here, ADCYAP1 is linked to retinopathy of prematurity.